Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00555503 · ClinicalTrials.gov registry record
Registry of Mastectomy for Breast Cancer Risk Reduction
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 261
- Enrollment target
NCT00555503 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 261 participants.
The verdict
NCT00555503 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 261 participants
- Enrollment target
Study Summary
This is a registry for patients who have a risk-reduction mastectomy ("prophylactic mastectomy") due to being at high risk for developing breast cancer, followed by breast reconstruction. Eligible patients include those who have a breast cancer-related gene, a strong family history of breast cancer, or a personal history of high-risk conditions such as cancer in the other breast or ductal carcinoma in situ (DCIS). Patients are enrolled in the registry before surgery, and are followed for up to ten years afterwards. In addition to studying medical outcomes, we will periodically survey patients for quality-of-life issues and psychological well-being. There is no compensation for being enrolled in this registry. This registry is conducted through the Department of Plastic Surgery at Georgetown University Hospital, and is a sub-registry to the Fisher Familial Cancer Registry at the Lombardi Comprehensive Cancer Center at Georgetown University.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2007-11 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00555503
The ClinicalTrials.gov registry entry for NCT00555503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 261 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00555503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00555503 about?
NCT00555503 is a clinical study titled "Registry of Mastectomy for Breast Cancer Risk Reduction". This is a registry for patients who have a risk-reduction mastectomy ("prophylactic mastectomy") due to being at high risk for developing breast cancer, followed by breast reconstruction. Eligible patients include those who have a breast cancer-related gene, a strong family history of breast cancer,...
What is the current status of trial NCT00555503?
This trial is currently completed. The enrollment target is 261 participants. The study started on 2007-11. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT00555503?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.